Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes Meeting Abstract
| Authors: | Mazieres, J.; Veillon, R.; Cortot, A.; Ferrara, R.; Felip, E.; Garassino, M.; Le, X.; Thomas, M.; Sakai, H.; Smit, E.; Raskin, J.; Viteri, S.; Yang, J. C. H.; Ahn, M. J.; Wu, Y. L.; Zhao, J.; Ghori, V.; Bruns, R.; Johne, A.; Paik, P. |
| Abstract Title: | Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2025 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 20 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2025 Mar 26-29 |
| Meeting Location: | Paris, France |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2025-03-01 |
| Start Page: | S59 |
| End Page: | S60 |
| Language: | English |
| ACCESSION: | WOS:001469780300080 |
| PROVIDER: | wos |
| DOI: | 10.1016/s1556-0864(25)00276-x |
| Notes: | Meeting Abstract: 81P -- Source: Wos |
